Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Cefuroxime (125mg) + Clavulanic Acid (31.25mg)
Therapeutic Category
Antibiotic, Pediatrics, Respiratory, ENT
Dosage Form
Dry Syrup
Packaging Type
Bottle
Packaging
60ml
Price
₹279/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Cefuzrom CV Dry Syrup is a powerful antibiotic combination of Cefuroxime, a second-generation cephalosporin, and Clavulanic Acid, a beta-lactamase inhibitor. This formulation is designed to treat a variety of bacterial infections by enhancing the effectiveness of Cefuroxime against beta-lactamase-producing organisms, which would otherwise be resistant to antibiotics. Cefuroxime works by interfering with the synthesis of bacterial cell walls, leading to bacterial death, while Clavulanic Acid protects the antibiotic from degradation by bacterial enzymes.
This combination is particularly useful for treating respiratory infections, urinary tract infections (UTIs), skin and soft tissue infections, and infections of the upper respiratory tract, such as otitis media and sinusitis. Cefuzrom CV is also prescribed for community-acquired pneumonia, bronchitis, and infections caused by susceptible strains of E. coli, Streptococcus pneumoniae, and other common bacterial pathogens.
Common side effects include nausea, diarrhea, and rash. Severe reactions like liver issues and allergic reactions are rare.
Treatment of respiratory tract infections, urinary tract infections, and skin infections caused by susceptible bacteria.
Consult a doctor before use if you have a history of allergies to antibiotics or liver disease.
Store at room temperature, away from heat and light. Once reconstituted, refrigerate and use within the specified period.
Composition : Amoxycillin (200mg) + Clavulanic Acid (28.5mg)
Composition : Amoxycillin (400mg/5ml) + Clavulanic Acid (57mg/5ml)
Composition : Artemether (40mg/5ml) + Lumefantrine (240mg/5ml) Dry Syrup
Composition : Cefalexin (125mg)
Composition : Cefixime (100mg/5ml)
Composition : Cefixime (50mg/5ml) + Clavulanic Acid (31.25mg/5ml)
Composition : Cefixime (50mg) + Ofloxacin (50mg)
Composition : Cefixime (50mg/5ml)
Composition : Cefpodoxime Proxetil (100mg/5ml)
Composition : Cefpodoxime Proxetil (50mg) + Clavulanic Acid (31.25mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Cefuroxime 125mg + Clavulanic Acid 31.25mg Dry Syrup has strong demand in the pediatric, anti-infective, and general healthcare segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on pediatric antibiotic portfolios.
Medical distributors and agencies can benefit from consistent demand for pediatric bacterial infection management under medical supervision. Cefuroxime is a second-generation cephalosporin antibiotic effective against a wide range of bacteria Clavulanic Acid is a beta-lactamase inhibitor that enhances antibiotic effectiveness against resistant organisms Commonly prescribed for respiratory tract infections, ear infections, sinusitis, throat infections, urinary tract infections, and skin infections in children as advised by physicians Helps improve treatment effectiveness against beta-lactamase producing bacteria Dry syrup formulation is easy to administer and suitable for pediatric patients after reconstitution Widely prescribed by pediatricians, ENT specialists, and general physicians This strengthens a comprehensive pediatric and anti-infective portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Cefuroxime 125mg + Clavulanic Acid 31.25mg Dry Syrup with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong pediatric prescription demand, steady seasonal and year-round usage, reliable supply chain support, and attractive margins in the antibiotic segment.
How can I become a distributor or franchise partner for this product?